BioRender Competitors

Adobe empowers everyone, everywhere to imagine, create, and bring any digital experience to life. From creators and students to small businesses, global enterprises, and nonprofit organizations — customers choose Adobe products to ideate, collaborate, be more productive, drive business growth, and build remarkable experiences.

We're a global online visual communications platform on a mission to empower the world to design. Featuring a simple drag-and-drop user interface and a vast range of templates ranging from presentations, documents, websites, social media graphics, posters, apparel to videos, plus a huge library of fonts, stock photography, illustrations, video footage, and audio clips, anyone can take an idea and create something beautiful on Canva on any device, from anywhere in the world. Since our launch in 2013, we’ve had the crazy big goal of making design accessible to everyone. We were founded on the belief that people shouldn't need to understand complex software to unlock their creativity. We’re leveling the playing field and democratizing access to design and visual communication by empowering 100% of the world to communicate in a way that was once limited to the 1%. We've always had a deeper mission surrounding Canva — which we talk about as our 'simple' two-step plan: to build one of the world’s most valuable companies, and to do the most good we possibly can. We're committed to our core value of Being a Force for Good, so as the value of our company grows, so too does our ability to have a positive impact on the world.

Servier is an independent international pharmaceutical group governed by a foundation. With its unique governance model, the Group is committed to therapeutic progress to serve patients and integrates the patient voice at every stage of the medicine life cycle. As a leading global player in cardiology and venous diseases, Servier aims to become a leading innovator in oncology and neurology. Through precision medicine, the Group intends to offer targeted therapeutic solutions for a limited number of rare diseases and invests nearly 20% of its brand-name sales in R&D. Headquartered in France, Servier relies on its more than 20,000 employees and a solid geographic presence with medicines distributed in more than 130 countries. In the 2024/25 financial year, the Group achieved revenues of €6.9 billion. -- To report a suspected adverse event with a Servier drug, please visit servier.com